pAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2643-2647

  Fiano, Valentina ^a   Ghimenti, Chiara ^a   Imarisio, Sara ^a   Silengo, Lorenzo ^a   Schiffer, Davide ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Akt; EGFR; Glioblastoma; PTEN

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P27;

ARTICLE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; NICK END LABELING; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL CYCLE PROTEINS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE AMPLIFICATION; GENES, ERBB-1; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 6444243685     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK and Huang HJ: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727-7731, 1994.
2. Frederick L, Wang XY, Eley G and James CD: Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 60: 1383-1387, 2000.
3. Liu W, James CD, Frederick L, Alderete E and Jenkins RB: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57: 5254-5257, 1997.
4. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL and Mischel PS: Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63: 2742-274, 2003.
5. Wang SI, Puc J, Li J, Bruce JN, Cairns P. Sidransky D and Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186, 1997.
6. Boström J, Cobbers JMJL, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP and Reifenberger G: Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q, Cancer Res 58: 29-33, 1998.
7. Schlegel J, Piontek G and Mennel HD: Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo. Anticancer Res 22: 2837-2840, 2002.
8. Medema RH, Kops GJPL, Bos JL and Burgering BMT: AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27/Kip.1. Nature 404: 782-787, 2000.
9. De Ruiter ND, Burgering BM and Bose JL: Regulation of the forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451. Mol Cell Biol 21: 8225-8235, 2001.
10. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN and Rosen N: Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/akt-dependent pathway. J Biol Chem 275: 29864-29872, 1998.
11. Chakrabarty A, Bridges L and Gray S: Cyclin D1 in astrocytic tumours: an immunohistochemical study. Neuropathol Appl Neurobiol 22: 311-316, 1996.
12. Cavalla P, Dutto A, Piva R, Richiardi P, Grosso R and Schiffer D: Cyclin D1 expression in gliomas. Acta Neuropathol 95: 131-135, 1998.
13. Sallinen SL, Sallinen PK, Kononen JT, Syriakkoski KM, Nupponen NN, Rantala IS, Helen PT, Helin HJ and Haapasalo HK: Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis. J Pathol 188: 289-293, 1999.
14. Allan K, Jordan RCK, Ang L -C, Taylor M and Young B: Overexpression of cyclin A and cyclin B1 proteins in astrocytomas. Arch Pathol Lab Med 124: 216-220, 2000.
15. Ren Y, Munyer P, Kepes JJ, Cansler M, Collins J, Gayed B and Tawfik O: Comparison of cyclin A and MIB.1 expression in astrocytic tumors using image-based cell analysis system. Appl Immunohistochem Mol Morphol 9: 14-19, 2001.
16. Fiano V, Ghimenti C and Schiffer D: Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans. Neurosci Lett 347: 111-115, 2003.
17. Buschges R, Weber RG, Actor B, Lichter P, Collins VP and Reifenberger G: Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol 9: 435-442, 1999.
18. Piva R, Cavalla P, Bortolotto S, Cordera S, Richiardi P and Schiffer D: p27/Kip.1 expression in astrocytic gliomas. Neurosci Lett 234: 127-130, 1997.
19. Cavalla P, Piva R, Bortolotto S, Grosso R, Cancelli I, Chio A and Schiffer D: p27/Kip.1 expression in oligodendrogliomas and its possible prognostic role. Acta Neuropathol 98: 629-634, 1999.
20. Narita Y, Nagane M, Mishima K, Su Huang H-J, Furnari FB and Cavenee WK: Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res 62: 6764-6769, 2002.
21. Kirla RM, Haapasalo HK, Kalimo H and Sallinen EK: Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 97: 644-648, 2003.
22. Piva R, Cancelli I, Cavalla P, Bortolotto S, Dominguez J, Draetta GF and Schiffer D: Proteasome-dependent degradation of p27/Kip.1 in gliomas. J Neuropathol Exp Neuro 58: 691-696, 1999.
23. Kipreos MT and Pagano M: The F-box protein family. Genom Biol 1: 3002, 2000.
24. Schiffer D, Cavalla P, Fiano V, Ghimenti C and Piva R: Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot. Neurosci Lett 328: 125-128, 2002.
25. Hunter SB, Abbott K, Varma VA and Olson JJ: Reliability of differential PCR for the detection of EWGHFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 54: 57-64, 1995.
26. Minaguchi T, Yoshikawa H, Oda K, Ishino T, Yasugi T, Onda T, Nakagawa S, Matsumoto K, Kawana K and Taketani Y: PTEN mutation located only outside exons 5, 6 and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin Cancer Res 7: 2636-2642, 2001.
27. Risinger JI, Hayes AK, Berchuck A and Barrett JC: PTEN MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736-4738, 1997.
28. Kleihues P and Cavenee WK: Pathology and Genetics. Tumours of the Nervous System. Lyon: IARC, 2000.
29. Graff JR, Konicek BW, McNulty AM, Wang Z, Houk K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL and Neubauer BL: Increased Akt activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip.1 expression. J Biol Chem 275: 24500-24505, 2000.
30. Weng L-P, Brown JL and Eng C: PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Gent 10: 599-604, 2001.
31. Kurose K, Zhou X-P, Araki T, Cannistra SA, Maher ER and Eng C: Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Amer J Pathol 158: 2097-2106, 2001.
32. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-868, 1999.
33. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G and Stokoe D: Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 21: 1195-1198, 1998.
34. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-57, 2000.
35. Schmidt MC, Antweiler S, Urban N, Mueller W, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R and von Deimling A: Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61: 321-328, 2002.
36. Huncharek M and Kupelnick B: Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. Oncol Res 12: 107-112, 2000.
37. Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG2nd and Aldape K: Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61: 1122-1128, 2001.
38. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK and Steck PA: Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59: 1820-1824, 1999.
39. Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G and Hamelm R: Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer 84: 150-154, 1999.
40. Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctiss S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES and Fisher RA: Loss of chromosome 120 is an independent prognostic factor in high-grade gliomas. Br J Cancer 81: 1371-1377, 1999.
41. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D and Haas-Kogan DA: Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8: 1100-1106, 2002.
42. Li DM and Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. PNAS USA 95: 15406-15411, 1998.
43. Cheney IW, Neutebool STC, Vaillancourt M-T, Ramachandra M and Bookstein R: Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27/Kip.1 into cyclin E/CDK2 complexes. Cancer Res 99: 2318-2323, 1999.
44. Simpson K and Parsons R: PTEN: life as a tumor suppression. Exp Cell Res 264: 29-41, 2001.